# EMVI as a Determinant of Metastasis in Colorectal Cancer

> **NCT06646341** · — · RECRUITING · sponsor: **Imperial College London** · enrollment: 100 (estimated)

## Conditions studied

- Colo-rectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06646341
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646341, "EMVI as a Determinant of Metastasis in Colorectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06646341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*